The cost of not re-testing: HIV misdiagnosis in the ART ‘test-and-offer’ era

Article published in Clinical Infectious Diseases - April 2017

Jeffrey W Eaton, Cheryl C Johnson, Simon Gregson

Publication details

Number of pages: 12
Publication date: April 2017
Languages: English
ISBN: DOI: 10.1080/09540121.2017.1317710



We compared estimated costs of re-testing HIV-positive persons before ART initiation to the costs of ART provision to misdiagnosed HIV-negative persons.

Savings from averted unnecessary ART costs were greater than re-testing costs within one year using assumptions representative of HIV testing performance in programmatic settings.

Countries should implement re-testing before ART initiation.

Related links